Opioid reversal medication is a medication that can save lives by temporarily reversing an opioid overdose, such as heroin or fentanyl. Opioid reversal medication is safe to use and only works if a person has opioids in their body. You are protected under the Good Samaritan Law and cannot be arrested if you use opioid reversal medication.
The #notscarytocarry campaign was created by a network of community organizations titled the Prescription Opioid Solutions (PRxOS) workgroups. The aim is to spread awareness of what opioid reversal medication is, why it’s important, and to break down the stigma surrounding opioid reversal medication. It’s not scary to carry, and it can save someone’s life.
Opioid Settlement Funding Opportunity
Thank you for your interest in funding from the Panhandle Health District Opioid Settlement Funds.
Requests must meet the scope of work outlined in Exhibit A. Only typed applications will be accepted. Only applications submitted in Word format without modifications to original application formatting will be accepted.
Expenditures are subject to Panhandle Health District’s purchasing and cost allocation policies and the Idaho Opioid Settlement Intrastate Allocation Agreement’s Abatement Strategies. A signed contract is required prior to any reimbursement or award spending. Those awarded funding will be required to submit reporting as set forth in the application to ensure compliance. For additional resources please refer to Exhibit A located on the Idaho Attorney General’s Office website: Exhibit-A-Approved-Uses.pdf (idaho.gov)
These requests are reviewed on a yearly basis. Please see the breakdown below:
Applications Available: January 29, 2024
Application Submissions Accepted Beginning:February 26, 2024
Applications Close: March 31, 2024
Notices: May 1, 2024
Funding Begins: July 1, 2024
Funding Ends: June 30, 2025
Awards will be based on size of need, reasonableness and are at the discretion of PHD. Notification of award or declination will be delivered via email listed in the application.